Adenovirus infection after allogeneic stem cell transplantation

Leukemia and Lymphoma

Volumn 48, Issue 2, 2007, Pages 244-255

  Feuchtinger, Tobias ^a   Lang, Peter ^a   Handgretinger, Rupert ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; CYCLOSPORIN; PROBENECID; RIBAVIRIN; ANTIVIRUS AGENT; CYTOSINE; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL ACTIVITY; CD8+ T LYMPHOCYTE; CELL THERAPY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DONOR LYMPHOCYTE INFUSION; DOSE KIDNEY FUNCTION RELATION; DRUG DOSE REDUCTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HYDRATION; IMMUNE RESPONSE; INCIDENCE; INFECTION RISK; MORBIDITY; MORTALITY; NEPHROTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; T CELL DEPLETION; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS ISOLATION; ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN ADENOVIRUS; PHYSIOLOGY;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ANTIVIRAL AGENTS; CYTOSINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PHOSPHONIC ACIDS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247842876     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600881157     Document Type: Review

References (111)

1. Handgretinger, R., Lang, P., Schumm, M., Pfeiffer, M., Gottschling, S., Demirdelen, B. and Bader, P. (2001) Immunological aspects of haploidentical stem cell transplantation in children. Ann NY Acad Sci, 938, pp. 340-357.
2. + progenitor cells from unrelated donors in pediatric leukemia. Blood, 101, pp. 1630-1636.
3. Lewin, S. R., Heller, G., Zhang, L., Rodrigues, E., Skulsky, E., Brink, M R van den and Small, T. N. (2002) Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood, 100, pp. 2235-2242.
4. Bahceci, E., Epperson, D., Douek, D. C., Melenhorst, J. J., Childs, R. C. and Barrett, A. J. (2003) Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism. Br J Haematol, 122, pp. 934-943.
5. Mohty, M., Jacot, W., Faucher, C., Bay, J. O., Zandotti, C., Collet, L. and Choufi, B. (2003) Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. Leukemia, 17, pp. 2168-2177.
6. Lion, T., Baumgartinger, R., Watzinger, F., Matthes-Martin, S., Suda, M., Preuner, S. and Futterknecht, B. (2003) Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood, 102, pp. 1114-1120.
7. Walls, T., Shankar, A. G. and Shingadia, D. (2003) Adenovirus: An increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis, 3, pp. 79-86.
8. Flomenberg, P., Babbitt, J., Drobyski, W. R., Ash, R. C., Carrigan, D. R., Sedmak, G. V. and McAuliffe, T. (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis, 169, pp. 775-781.
9. Shirali, G. S., Chinnock, R. E., Johnston, J. K., Rosenthal, G. L., Bowles, N. E. and Towbin, J. A. (2001) Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med, 344, pp. 1498-1503.
10. Kojaoghlanian, T., Flomenberg, P. and Horwitz, M. S. (2003) The impact of adenovirus infection on the immunocompromised host. Rev Med Virol, 13, pp. 155-171.
11. Chakrabarti, S., Mautner, V., Osman, H., Collingham, K. E., Fegan, C. D., Klapper, P. E. and Moss, P. A. (2002) Adenovirus infections following allogeneic stem cell transplantation: Incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood, 100, pp. 1619-1627.
12. Feuchtinger, T., Lucke, J., Hamprecht, K., Richard, C., Handgretinger, R., Schumm, M. and Greil, J. (2005) Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol, 128, pp. 503-509.
13. Heemskerk, B., Lankester, A. C., van Vreeswijk, T., Beersma, M. F., Claas, E. C., Veltrop-Duits, L. A. and Kroes, A. C. (2005) Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis, 191, pp. 520-530.
14. Shields, A. F., Hackman, R. C., Fife, K. H., Corey, L. and Meyers, J. D. (1985) Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med, 312, pp. 529-533.
15. Bruno, B., Zager, R. A., Boeckh, M. J., Gooley, T. A., Myerson, D. H., Huang, M. L. and Hackman, R. C. (2004) Adenovirus nephritis in hematopoietic stem-cell transplantation. Transplantation, 77, pp. 1049-1057.
16. Davison, A. J., Benko, M. and Harrach, B. (2003) Genetic content and evolution of adenoviruses. J Gen Virol, 84, pp. 2895-2908.
17. Russell, W. C. (2000) Update on adenovirus and its vectors. J Gen Virol, 81, pp. 2573-2604.
18. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S. and Horwitz, M. S. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, 275, pp. 1320-1323.
19. Gaggar, A., Shayakhmetov, D. M. and Lieber, A. (2003) CD46 is a cellular receptor for group B adenoviruses. Nat Med, 9, pp. 1408-1412.
20. Amberg, N., Edlund, K., Kidd, A. H. and Wadell, G. (2000) Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol, 74, pp. 42-48.
21. Shayakhmetov, D. M., Li, Z. Y., Ternovoi, V., Gaggar, A., Gharwan, H. and Lieber, A. (2003) The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol, 77, pp. 3712-3723.
22. Leopold, P. L., Kreitzer, G., Miyazawa, N., Rempel, S., Pfister, K. K., Rodriguez-Boulan, E. and Crystal, R. G. (2000) Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther, 11, pp. 151-165.
23. Schmitz, H., Wigand, R. and Heinrich, W. (1983) Worldwide epidemiology of human adenovirus infections. Am J Epidemiol, 117, pp. 455-466.
24. Flomenberg, P., Piaskowski, V., Truitt, R. L. and Casper, J. T. (1995) Characterization of human proliferative T cell responses to adenovirus. J Infect Dis, 171, pp. 1090-1096.
25. Sester, M., Sester, U., Salvador, S. A., Heine, G., Lipfert, S., Girndt, M. and Gartner, B. (2002) Age-related decrease in adenovirus-specific T cell responses. J Infect Dis, 185, pp. 1379-1387.
26. Adrian, T., Schafer, G., Cooney, M. K., Fox, J. P. and Wigand, R. (1988) Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiol Infect, 101, pp. 503-509.
27. Fox, J. P., Brandt, C. D., Wassermann, F. E., Hall, C. E., Spigland, I., Kogon, A. and Elveback, L. R. (1969) The Virus Watch Program: A continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: Virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol, 89, pp. 25-50.
28. Fox, J. P., Hall, C. E. and Cooney, M. K. (1977) The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol, 105, pp. 362-386.
29. Garnett, C. T., Erdman, D. and Gooding, L. R. (2002) Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol, 76, pp. 10608-10616.
30. Wold, W. S., Doronin, K., Toth, K., Kuppuswamy, M., Lichtenstein, D. L. and Tollefson, A. E. (1999) Immune responses to adenoviruses: Viral evasion mechanisms and their implications for the clinic. Curr Opin Immunol, 11, pp. 380-386.
31. + T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol, 70, pp. 6314-6322.
32. Wold, W. S. and Gooding, L. R. (1989) Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol Biol Med, 6, pp. 433-452.
33. Wold, W. S. and Gooding, L. R. (1991) Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology, 184, pp. 1-8.
34. Cotter, M. J., Zaiss, A. K. and Muruve, D. A. (2005) Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J Virol, 79, pp. 14622-14631.
35. Liu, Z. X., Govindarajan, S., Okamoto, S. and Dennert, G. (2000) NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol, 164, pp. 6480-6486.
36. Ruzek, M. C., Kavanagh, B. F., Scaria, A., Richards, S. M. and Garman, R. D. (2002) Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression. Mol Ther, 5, pp. 115-124.
37. Lang, P., Griesinger, A., Hamprecht, K., Feuchtinger, T., Schumm, M., Neuhauser, F. and Greil, J. (2004) Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors. Hum Immunol, 65, pp. 423-431.
38. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med, 187, pp. 1395-1402.
39. + T cells in acute infectious mononucleosis. Nat Med, 2, pp. 906-911.
40. + T cells during an acute virus infection. Immunity, 8, pp. 167-175.
41. Molinier-Frenkel, V., Gahery-Segard, H., Mehtali, M., Boulaire, C Le, Ribault, S., Boulanger, P. and Tursz, T. (2000) Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol, 74, pp. 7678-7682.
42. Smith, C. A., Woodruff, L. S., Kitchingman, G. R. and Rooney, C. M. (1996) Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J Virol, 70, pp. 6733-6740.
43. Smith, C. A., Woodruff, L. S., Rooney, C. and Kitchingman, G. R. (1998) Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Hum Gene Ther, 9, pp. 1419-1427.
44. + adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol, 77, pp. 6562-6566.
45. Molinier-Frenkel, V., Lengagne, R., Gaden, F., Hong, S. S., Choppin, J., Gahery-Segard, H. and Boulanger, P. (2002) Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol, 76, pp. 127-135.
46. Rux, J. J., Kuser, P. R. and Burnett, R. M. (2003) Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J Virol, 77, pp. 9553-9566.
47. + T-cell epitope. Hum Gene Ther, 13, pp. 1167-1178.
48. Tang, J., Olive, M., Champagne, K., Flomenberg, N., Eisenlohr, L., Hsu, S. and Flomenberg, P. (2004) Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther, 11, pp. 1408-1415.
49. +T cells. Blood, 104, pp. 2432-2440.
50. Bicanic, O., Richard, C., Stevanovic, S., Lang, P., Wernet, K., Hamprecht, K. and Schumm, M. (2005) Analysis of the adenovirus specific T-cell response, using MHC-I peptides of the adenoviral hexon-protein for the detection and isolation of specific T-cells. Bone Marrow Transplant, 35, p. S25.
51. Runde, V., Ross, S., Trenschel, R., Lagemann, E., Basu, O., Renzing-Kohler, K. and Schaefer, U. W. (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): Report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant, 28, pp. 51-57.
52. Howard, D. S., Phillips II, G. L., Reece, D. E., Munn, R. K., Henslee-Downey, J., Pittard, M. and Barker, M. (1999) Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis, 29, pp. 1494-1501.
53. Baldwin, A., Kingman, H., Darville, M., Foot, A. B., Grier, D., Cornish, J. M. and Goulden, N. (2000) Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant, 26, pp. 1333-1338.
54. van Tol, M. J., Kroes, A. C., Schinkel, J., Dinkelaar, W., Claas, E. C., der Zijde, C M Jol-van and Vossen, J. M. (2005) Adenovirus infection in paediatric stem cell transplant recipients: Increased risk in young children with a delayed immune recovery. Bone Marrow Transplant, 36, pp. 39-50.
55. La Rosa, A. M., Champlin, R. E., Mirza, N., Gajewski, J., Giralt, S., Rolston, K. V. and Raad, I. (2001) Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis, 32, pp. 871-876.
56. Bruno, B., Boeck, M., Davis, C., Gooley, T. and Hackman, R. C. (1997) Adenovirus infections in patients undergoing bone marrow transplantation. Blood (Suppl.), p. 1867a.
57. Hale, G. A., Heslop, H. E., Krance, R. A., Brenner, M. A., Jayawardene, D., Srivastava, D. K. and Patrick, C. C. (1999) Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant, 23, pp. 277-282.
58. Myers, G. D., Krance, R. A., Weiss, H., Kuehnle, I., Demmler, G., Heslop, H. E. and Bollard, C. M. (2005) Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant, 36, pp. 1001-1008.
59. Echavarria, M., Forman, M., van Tol, M. J., Vossen, J. M., Charache, P. and Kroes, A. C. (2001) Prediction of severe disseminated adenovirus infection by serum PCR. Lancet, 358, pp. 384-385.
60. Schilham, M. W., Claas, E. C., van Zaane, W., Heemskerk, B., Vossen, J. M., Lankester, A. C. and Toes, R. E. (2002) High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis, 35, pp. 526-532.
61. Kampmann, B., Cubitt, D., Walls, T., Naik, P., Depala, M., Samarasinghe, S. and Robson, D. (2005) Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol, 130, pp. 595-603.
62. Bredius, R. G., Templeton, K. E., Scheltinga, S. A., Claas, E. C., Kroes, A. C. and Vossen, J. M. (2004) Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. Pediatr Infect Dis J, 23, pp. 518-522.
63. Allard, A., Girones, R., Juto, P. and Wadell, G. (1990) Polymerase chain reaction for detection of adenoviruses in stool samples. J Clin Microbiol, 28, pp. 2659-2667.
64. Pring-Akerblom, P. and Adrian, T. (1994) Type- and group-specific polymerase chain reaction for adenovirus detection. Res Virol, 145, pp. 25-35.
65. Pring-Akerblom, P., Adrian, T. and Kostler, T. (1997) PCR-based detection and typing of human adenoviruses in clinical samples. Res Virol, 148, pp. 225-231.
66. Echavarria, M., Forman, M., Ticehurst, J., Dumler, J. S. and Charache, P. (1998) PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol, 36, pp. 3323-3326.
67. Heim, A., Ebnet, C., Harste, G. and Pring-Akerblom, P. (2003) Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol, 70, pp. 228-239.
68. Claas, E. C., Schilham, M. W., de Brouwer, C. S., Hubacek, P., Echavarria, M., Lankester, A. C. and van Tol, M. J. (2005) Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol, 43, pp. 1738-1744.
69. Lankester, A. C., van Tol, M. J., Claas, E. C., Vossen, J. M. and Kroes, A. C. (2002) Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin Infect Dis, 34, pp. 864-867.
70. Ebner, K., Suda, M., Watzinger, F. and Lion, T. (2005) Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay. J Clin Microbiol, 43, pp. 3049-3053.
71. Cromeans, T. L. and Sobsey, M. D. (2003) Detection of infectious adenovirus in cell culture by mRNA reverse transcription-PCR. Appl Environ Microbiol, 69, pp. 7377-7384.
72. Morfin, F., Dupuis-Girod, S., Mundweiler, S., Falcon, D., Carrington, D., Sedlacek, P. and Bierings, M. (2005) In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther, 10, pp. 225-229.
73. Stock, R., Harste, G., Madisch, I. and Heim, A. (2006) A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity. Antiviral Res, 72, pp. 34-41.
74. Malasig, M. D., Goswami, P. R., Crawford-Miksza, L. K., Schnurr, D. P. and Gray, G. C. (2001) Simplified microneutralization test for serotyping adenovirus isolates. J Clin Microbiol, 39, pp. 2984-2986.
75. Takeuchi, S., Itoh, N., Uchio, E., Aoki, K. and Ohno, S. (1999) Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol, 37, pp. 1839-1845.
76. Allard, A., Albinsson, B. and Wadell, G. (2001) Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis. J Clin Microbiol, 39, pp. 498-505.
77. Walls, T., Hawrami, K., Ushiro-Lumb, I., Shingadia, D., Saha, V. and Shankar, A. G. (2005) Adenovirus infection after pediatric bone marrow transplantation: Is treatment always necessary?. Clin Infect Dis, 40, pp. 1244-1249.
78. Chakrabarti, S., Collingham, K. E., Stevens, R. H., Pillay, D., Fegan, C. D. and Milligan, D. W. (2000) Isolation of viruses from stools in stem cell transplant recipients: A prospective surveillance study. Bone Marrow Transplant, 25, pp. 277-282.
79. Hierholzer, J. C. (1992) Adenoviruses in the immunocompromised host. Clin Microbiol Rev, 5, pp. 262-274.
80. Childs, R., Sanchez, C., Engler, H., Preuss, J., Rosenfeld, S., Dunbar, C. and van Rhee, F. (1998) High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant, 22, pp. 889-893.
81. Akiyama, H., Kurosu, T., Sakashita, C., Inoue, T., Mori, S., Ohashi, K. and Tanikawa, S. (2001) Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis, 32, pp. 1325-1330.
82. Mori, K., Yoshihara, T., Nishimura, Y., Uchida, M., Katsura, K., Kawase, Y. and Hatano, I. (2003) Acute renal failure due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient. Bone Marrow Transplant, 31, pp. 1173-1176.
83. Chakrabarti, S., Collingham, K. E., Fegan, C. D. and Milligan, D. W. (1999) Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: Failure of intravenous ribavirin therapy. Bone Marrow Transplant, 23, pp. 1209-1211.
84. Johnson, P. R., Yin, J. A., Morris, D. J., Desai, M., Cinkotai, K. I. and McKeogh, M. M. (1990) Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation. Bone Marrow Transplant, 5, pp. 345-347.
85. Kinchington, P. R., Romanowski, E. G. and Jerold, G. Y. (2005) Prospects for adenovirus antivirals. J Antimicrob Chemother, 55, pp. 424-429.
86. Leruez-Ville, M., Minard, V., Lacaille, F., Buzyn, A., Abachin, E., Blanche, S. and Freymuth, F. (2004) Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis, 38, pp. 45-52.
87. Muller, W. J., Levin, M. J., Shin, Y. K., Robinson, C., Quinones, R., Malcolm, J. and Hild, E. (2005) Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis, 41, pp. 1812-1816.
88. Ljungman, P., Ribaud, P., Eyrich, M., Matthes-Martin, S., Einsele, H., Bleakley, M. and Machaczka, M. (2003) Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: A survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant, 31, pp. 481-486.
89. Bordigoni, P., Carret, A. S., Venard, V., Witz, F. and Faou, A Le (2001) Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis, 32, pp. 1290-1297.
90. Legrand, F., Berrebi, D., Houhou, N., Freymuth, F., Faye, A., Duval, M. and Mougenot, J. F. (2001) Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant, 27, pp. 621-626.
91. Hoffman, J. A., Shah, A. J., Ross, L. A. and Kapoor, N. (2001) Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 7, pp. 388-394.
92. Yusuf, U., Hale, G. A., Carr, J., Benaim, E., Woodard, P. and Kasow, K. A. (2006) Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation, 81, pp. 1398-1404.
93. Liles, W. C., Cushing, H., Holt, S., Bryan, C. and Hackman, R. C. (1993) Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant, 12, pp. 409-412.
94. Jurado, M., Navarro, J. M., Hernandez, J., Molina, M. A. and DePablos, J. M. (1995) Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Bone Marrow Transplant, 15, pp. 651-652.
95. Miyamura, K., Hamaguchi, M., Taji, H., Kanie, T., Kohno, A., Tanimoto, M. and Saito, H. (2000) Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant, 25, pp. 545-548.
96. Shetty, A. K., Gans, H. A., Millan, M. T., Arvin, A. M. and Gutierrez, K. M. (2000) Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol, 29, pp. 69-73.
97. Gavin, P. J. and Katz, B. Z. (2002) Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics, 110:1, p. e9.
98. Lankester, A. C., Heemskerk, B., Claas, E. C., Schilham, M. W., Beersma, M. F., Bredius, R. G. and van Tol, M. J. (2004) Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis, 38, pp. 1521-1525.
99. Greil, J., Bader, P., Lang, P., Beck, R., Feuchtinger, T. and Niethammer, D. (2003) Prophylactic ribavirin treatment prevents adenovirus infection in pediatric stem cell transplant recipients. Blood (Suppl), 102, p. 449B.
100. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K. and Handgretinger, R. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol, 134, pp. 64-76.
101. Rooney, C. M., Smith, C. A., Ng, C. Y., Loftin, S. K., Sixbey, J. W., Gan, Y. and Srivastava, D. K. (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood, 92, pp. 1549-1555.
102. Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D. and Riddell, S. R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med, 333, pp. 1038-1044.
103. Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J. and Grigoleit, U. (2002) Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood, 99, pp. 3916-3922.
104. Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E. and Greenberg, P. D. (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science, 257, pp. 238-241.
105. + T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol, 5, pp. 927-933.
106. Bevan, M. J. (2004) Helping the CD8(+) T-cell response. Nat Rev Immunol, 4, pp. 595-602.
107. Chakrabarti, S., Collingham, K. E., Fegan, C. D., Pillay, D. and Milligan, D. W. (2000) Adenovirus infections following haematopoietic cell transplantation: Is there a role for adoptive immunotherapy?. Bone Marrow Transplant, 26, pp. 305-307.
108. Hromas, R., Cornetta, K., Srour, E., Blanke, C. and Broun, E. R. (1994) Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood, 84, pp. 1689-1690.
109. Moss, P. and Rickinson, A. (2005) Cellular immunotherapy for viral infection after HSC transplantation. Nat Rev Immunol, 5, pp. 9-20.
110. Leen, A. M. and Rooney, C. M. (2005) Adenovirus as an emerging pathogen in immunocompromised patients. Br J Haematol, 128, pp. 135-144.
111. + T-cells According To IFN-gamma Secretion For Adjuvant Immunotherapy. Exp Hematol, 32, pp. 282-289.